Sodium Methanesulfinate CAS 20277-69-4 Purity >96.0% Factory High Purity

Chemical Name: Sodium Methanesulfinate  CAS: 20277-69-4 Appearance: White or Off-White Crystal Powder Purity: >96.0%   Inquiry: alvin@ruifuchem.com 

Products Details

Chemical Properties:

Manufacturer Supply Related Intermediates: Sodium Methanesulfinate CAS 20277-69-4 2-Aminoethyl Methyl Sulfone Hydrochloride CAS 104458-24-4 6-Iodo-4-Hydroxyquinazoline CAS 16064-08-7 5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde CAS 231278-84-5 CAS 231277-92-2 CAS 388082-77-7
Item Specifications
Appearance White or Off-White Crystal Powder
Purity >96.0%
Loss on drying <1.00%
Infrared Spectrum Conforms to Structure
Proton NMR Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates; Organic Synthesis

Description:

Specifications:

Package & Storage:

Chemical Name Sodium Methanesulfinate
Synonyms Methanesulfinic Acid Sodium Salt
CAS Number 20277-69-4
CAT Number RF-PI112
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula CH5NaO2S
Molecular Weight 104.1
Water Solubility Soluble in Water 
Sensitive Air Sensitive & Hygroscopic
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. commercial supply Sodium Methanesulfinate (CAS: 20277-69-4). It is an important pharmaceutical intermediate, which can be used in the prodcution of API (CAS 231277-92-2) and (CAS 388082-78-8) API or other intermediates. (CAS 388082-78-8), a new member of the 4-anilinoquinazoline class of RTK inhibitors (RTKIs), was launched as an oral treatment for breast cancer. It has dual affinity for EGFR and HER2 tyrosine kinases. It is indicated in combination with Capecitabine for treating patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. 

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours